Literature DB >> 16198106

IBM-type inclusions in a patient with slow-channel syndrome caused by a mutation in the AChR epsilon subunit.

Anna Fidzianska1, B Ryniewicz, Xing-Ming Shen, Andrew G Engel.   

Abstract

We report a patient with a slow-channel congenital myasthenic syndrome who carries a novel slow-channel mutation in the epsilon subunit of the acetylcholine receptor and has tubulofilamentous inclusion bodies, in skeletal muscle of the type observed in hereditary and sporadic inclusion body myositis. Ultrastructural analysis of a muscle specimen obtained at the age of 9 years showed an endplate myopathy typical of the slow-channel syndrome. Twenty years later, a second muscle specimen again showed the endplate myopathy as well numerous nuclear and cytoplasmic tubulofilamentous inclusion bodies. Molecular genetic studies revealed a novel valine to phenylalanine mutation (epsilonV259F) in the M2 domain of the acetylcholine receptor. Coexistence of the slow-channel syndrome with a feature of IBM has not been observed before.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16198106     DOI: 10.1016/j.nmd.2005.07.009

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  4 in total

1.  Pathogenic point mutations in a transmembrane domain of the epsilon subunit increase the Ca2+ permeability of the human endplate ACh receptor.

Authors:  Amalia Di Castro; Katiuscia Martinello; Francesca Grassi; Fabrizio Eusebi; Andrew G Engel
Journal:  J Physiol       Date:  2007-02-01       Impact factor: 5.182

2.  Mutations Causing Slow-Channel Myasthenia Reveal That a Valine Ring in the Channel Pore of Muscle AChR is Optimized for Stabilizing Channel Gating.

Authors:  Xin-Ming Shen; Tatsuya Okuno; Margherita Milone; Kenji Otsuka; Koji Takahashi; Hirofumi Komaki; Elizabeth Giles; Kinji Ohno; Andrew G Engel
Journal:  Hum Mutat       Date:  2016-08-21       Impact factor: 4.878

3.  Determinants of the repetitive-CMAP occurrence and therapy efficacy in slow-channel myasthenia.

Authors:  Li Di; Hai Chen; Yan Lu; Duygu Selcen; Andrew G Engel; Yuwei Da; Xin-Ming Shen
Journal:  Neurology       Date:  2020-09-09       Impact factor: 9.910

4.  Congenital myasthenic syndrome in China: genetic and myopathological characterization.

Authors:  Yawen Zhao; Ying Li; Yang Bian; Sheng Yao; Penju Liu; Meng Yu; Wei Zhang; Zhaoxia Wang; Yun Yuan
Journal:  Ann Clin Transl Neurol       Date:  2021-03-23       Impact factor: 4.511

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.